Capital Analysts LLC
MDLN icon

Capital Analysts LLC’s Medline Inc MDLN Stock Holding History

Capital Analysts LLC’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$243 Buy
+7
New +$256 ﹤0.01% 1676

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return
H&F Corporate Investors X
H&F Corporate Investors X San Francisco, California $2.46B AUM 15.37% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Capital Analysts LLC's MDLN Position: Q3 2026 in Review

Capital Analysts LLC opened a new position in Medline Inc (MDLN) in Q3 2026: 7 shares worth $243. The stake represents ﹤0.01% of the portfolio and ranks #1676 among its holdings.

315 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Capital Analysts LLC held 7 shares of Medline Inc worth $243 as of Q3 2026.
  • Medline Inc was a new Capital Analysts LLC position in Q3 2026.
  • Medline Inc made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1676 holding.
  • 315 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.